Resources

Training and competency assessment tool for users of the STANDARD G6PD Test

Examples of patient G6PD counseling cards

Before the COVID-19 pandemic, important progress had been made in improving maternal, neonatal, and child health (MCH) outcomes around the globe, with under-five deaths and maternal mortality falling to historic lows by 2019. However, the onset of the COVID-19 pandemic and resulting mortality has wreaked havoc on broad health outcomes.Over the last two years, PATH has worked alongside governments, donors, and partners around the globe to respond to COVID-19 while working to mitigate its impact by preserving the delivery of essential health services. In early 2022, we conducted an internal analysis to explore COVID-19 disruptions–with a special focus on the impact to MCH essential services–and the innovations that were deployed to address these disruptions. We found that despite reduced budgets for MCH, overstretched workforces, and a reduced focus on universal health care, governments and their partners developed and used a range of innovations at the primary health care (PHC) level intended to safeguard MCH care.Read PATH's full set of recommendations for USAID maternal and child health programming below.

The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs. See also the companion resources:General summary (five pages)Technical synthesis (30 pages), of immunogenicity, efficacy, and effectiveness, forthcoming evidence, and areas for future research.Visit the Single-Dose HPV Vaccine Evaluation Consortium page for additional resources.

This report focuses on bed net indicators collected from annual cross-sectional surveys and anthropological activities. Within each evaluation, available indicators on bed net ownership, bed net characteristics, and bed net use are presented. Due to country-specific factors, the timing of data collection, management, and analysis varies. Data collection and analysis are ongoing, and definitive conclusions will not be drawn from these results at this time.The New Nets Project (NNP) was established with the goal of making the latest dual active ingredient (AI) insecticide-treated nets (ITNs) more widely available to malaria programs throughout sub-Saharan Africa. In addition to managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, NNP partners oversee randomized control trials and pilot studies evaluating their efficacy and effectiveness. The evidence gathered from these studies will be used to ascertain the impact and cost-effectiveness of dual AI nets and support an appropriate ITN policy recommendation from the World Health Organization. The NNP is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and US President’s Malaria Initiative. The project is led by IVCC.